Health
A rare clotting disorder may cloud the world’s hopes for AstraZeneca’s COVID-19 vaccine – Science Magazine
Researchers propose a mechanism and a treatment for possible deadly side effect seen in at least 30 European vaccine recipients
A man receives a dose of AstraZeneca’s COVID-19 vaccine at a conference center in Rome on 24 March. Italy halted use of the vaccine on 15 March but resumed immunizations four days later.
Antonio Masiello/Getty Images
By Kai Kupferschmidt, Gretchen VogelMar. 27, 2021 , 10:20 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
In the tumultuous rollout of AstraZeneca’s COVID-19 vaccine, all eyes were on the United States this week, where the company had a highly public communication…
-
General14 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General20 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News19 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business18 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?